Table 1.
Clinical details
| High Th1/Th2 ratio | Low Th1/Th2 ratio | p | |
|---|---|---|---|
| n | 125 | 89 | |
| Age (median [IQR]) * | 55.00 [48.00, 64.00] | 51.00 [46.00, 62.00] | 0.105 |
| Stage (%) * | |||
| Stage I/II | 106 (84.8) | 64 (71.9) | 0.365 |
| Stage III/IV | 18 (14.4) | 20 (22.5) | |
| Stage X | 1 (0.8) | 5 (5.6) | |
| Histological type (%) * | |||
| Infiltrating Ductal Carcinoma | 106 (84.8) | 74 (83.1) | 0.398 |
| Infiltrating Lobular Carcinoma | 7 (5.6) | 0 (0.0) | |
| Other | 12 (9.6) | 15 (16.9) | |
| Menopause status (%) | |||
| Pre | 39 (31.2) | 30 (33.7) | 0.535 |
| Post | 79 (63.2) | 51 (57.3) | |
| Unclear | 7 (5.6) | 8 (9.0) | |
* Data of age didn’t fit the normal distribution, and the p value was calculated by non-norm method; p value of data of stage and histological type were calculated by Fisher’s Exact Test